TRIPLE A INTERNATIONAL
MOLECULAR DIAGNOSTICS
ESTABLISH MOLECULAR DIAGNOSTICS LABORATORY
Oncology & Genetic Diseases
Our Group establishes Molecular Diagnostics laboratories for Oncology and Genetic Diseases, providing early detection for cancers.
Molecular Diagnostics facilitates correct treatment, saving valuable time in treatment compared with conventional clinical diagnosis.
Early detection of cancers increases the success of treatment and life expectancy is extended for patients.
Our Group establishes the capability and capacity of a fully functional Molecular Diagnostics laboratory with trained certified personnel for post diagnostic treatment and follow up care using smart therapy.
FINANCE -
MOLECULAR DIAGNOSTIC LABORATORY
Molecular diagnostics in cancer patients is an essential prerequisite for accurate disease diagnostics, prognosis and determination of appropriate therapy (smart therapy).
For many disorders, genetic testing and molecular diagnostics are the only method to make an accurate diagnosis and guide the clinicians in choosing the most suitable therapy and support for patients. In this manner, they help avoid additional unnecessary clinical investigations and expenses.
Upon completion of the project, the institution will be able to utilise the transferred technology for diagnostics, research, project development and execution, and testing tailored to the needs of the local population.
To date, our Group has completed 17 turnkey projects in 11 countries with post-completion support, service and consumables.
Financing options for the Turnkey Molecular Diagnostic laboratory is available and requires a Central Bank guarantee.
Presentation is available to Download.